Poellath advised Synlab’s board of directors on the deal. Clifford Chance has advised SYNLAB, Europe’s leading medical laboratory and diagnostic services company, and its majority shareholders…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now